A carregar...
Effect of Patiromer in Hyperkalemic Patients Taking and Not Taking RAAS Inhibitors
INTRODUCTION: Hyperkalemia (potassium >5.0 mEq/L) affects heart failure patients with renal disease regardless of the use of renin–angiotensin–aldosterone system inhibitors (RAASi). The open-label TOURMALINE study showed that patiromer, a sodium-free, nonabsorbed potassium binder, lowers serum po...
Na minha lista:
| Publicado no: | J Cardiovasc Pharmacol Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6193203/ https://ncbi.nlm.nih.gov/pubmed/30103622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1074248418788334 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|